Responses and durability of clinical benefit in renal cell carcinoma treated with pegilodecakin in combination with anti-PD-1 inhibitors
Tannir, N.M., Naing, A., Papadopoulos, K.P., Wong, D.J., Korn, W.M., Aljumaily, R., Autio, K.A., Pant, S., Bauer, T.M., Drakaki, A., Daver, N., Hung, A., Oft, M., Leveque, J.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
MORPHEUS: A phase Ib/II umbrella study platform evaluating the safety and efficacy of multiple cancer immunotherapy (CIT)-based combinations in different tumour types
Chau, I., Haag, G.M., Rahma, O.E., Macarulla, T.M., McCune, S.L., Yardley, D.A., Solomon, B.J., Johnson, M., Vidal, G.A., Schmid, P., Argiles, G., Dimick, K., Mahrus, S., Abdullah, H., He, X., Sayyed, P., Barak, H., Bleul, C., Cha, E., Drakaki, A.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
RANGE, a phase III, randomized, placebo-controlled, double-blind trial of ramucirumab (RAM) and docetaxel (DOC) in platinum-refractory urothelial carcinoma (UC): Overall survival results
Petrylak, D.P., Sternberg, C.N., Drakaki, A., de Wit, R., Nishiyama, H., Necchi, A., Castellano, D., Bamias, A., Chi, K.N., van der Heijden, M.S., Matsubara, N., Hussain, S., Flechon, A., Alekseev, B.Y., Yu, E.Y., Walgren, R.A., Russo, F., Zimmermann, A.H., Bell-Mcguinn, K.M., Powles, T.B.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Abstract No. 234 Long-Term Survival After Percutaneous CT and Contrast-Enhanced Ultrasound-Guided Microwave Ablation of Pathologically Proven Renal Cell Carcinoma
Kim, D., Chen, L., Drakaki, A., Shuch, B., Pantuck, A., McWilliams, J., Lu, D., Raman, S.
Published in Journal of vascular and interventional radiology (01.03.2024)
Published in Journal of vascular and interventional radiology (01.03.2024)
Get full text
Journal Article
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer
Powles, Thomas, Valderrama, Begoña P., Gupta, Shilpa, Bedke, Jens, Kikuchi, Eiji, Hoffman-Censits, Jean, Iyer, Gopa, Vulsteke, Christof, Park, Se Hoon, Shin, Sang Joon, Castellano, Daniel, Fornarini, Giuseppe, Li, Jian-Ri, Gümüş, Mahmut, Mar, Nataliya, Loriot, Yohann, Fléchon, Aude, Duran, Ignacio, Drakaki, Alexandra, Narayanan, Sujata, Yu, Xuesong, Gorla, Seema, Homet Moreno, Blanca, van der Heijden, Michiel S.
Published in The New England journal of medicine (07.03.2024)
Published in The New England journal of medicine (07.03.2024)
Get full text
Journal Article
Abstract No. 231 Long-Term Survival After Percutaneous Image-Guided Ablation of Oligometastatic Renal Cell Carcinoma
Kim, D., Suh, R., Abtin, F., Genshaft, S., Drakaki, A., Shuch, B., Pantuck, A., Lu, D., Raman, S.
Published in Journal of vascular and interventional radiology (01.03.2024)
Published in Journal of vascular and interventional radiology (01.03.2024)
Get full text
Journal Article
1970MO Circulating tumor DNA (ctDNA) clearance with neoadjuvant durvalumab (D) + tremelimumab (T) + enfortumab vedotin (EV) for cisplatin-ineligible muscle-invasive bladder cancer (MIBC) from the safety run-in cohort of the phase III VOLGA trial
Drakaki, A., Powles, T.B., Wang, Y., Bupathi, M., Joshi, M., Fleming, M.T., Gomez de Liano Lista, A., Morales Barrera, R., Pili, R., Boulos, S., Shrestha, Y.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
A0746 - Phase 3 study of disitamab vedotin with pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial carcinoma that expresses HER2 (DV-001; trial in progress)
Powles, T., Grande, E., Van Der Heijden, M., Necchi, A., Iyer, G., Drakaki, A., Loriot, Y., Sokolowski, K., Zhang, W., Galsky, M.
Published in European urology (01.03.2024)
Published in European urology (01.03.2024)
Get full text
Journal Article
Phase 3 study of disitamab vedotin with pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial carcinoma that expresses HER2 (DV-001; trial in progress)
Powles, T., Grande, E., Van Der Heijden, M., Necchi, A., Iyer, G., Drakaki, A., Loriot, Y., Sokolowski, K., Zhang, W., Galsky, M.
Published in European urology (01.03.2024)
Published in European urology (01.03.2024)
Get full text
Journal Article
1967MO Preliminary efficacy and safety of disitamab vedotin (DV) with pembrolizumab (P) in treatment (Tx)-naive HER2-expressing, locally advanced or metastatic urothelial carcinoma (la/mUC): RC48G001 cohort C
Galsky, M.D., Koshkin, V.S., Campbell, M.T., Drakaki, A., Bowman, I., Rose, A.A.N., Brown, J.R., Aragon-Ching, J.B., Gadde, S., Harandi, A., Rosenberg, J.E., Matsubara, N., Sokolowski, K.M., Ichimaru, M., Chan, S., Franco, S., Powles, T.B.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1779TiP Phase II clinical study evaluating the efficacy and safety of disitamab vedotin in patients (pts) with HER2-expressing urothelial carcinoma (RC48G001)
Koshkin, V.S., Powles, T.B., Iyer, G., Loriot, Y., Drakaki, A., Duran Martinez, I., De Santis, M., Retz, M., Jain, R.K., Chan, S., Ichimaru, M., Galsky, M.D.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
FP08.03 Outcomes With Multi-Disciplinary Management of Central Lung Tumors Treated With Percutaneous High-Dose-Rate Brachytherapy
Yoon, S., Suh, R., Abtin, F., Moghanaki, D., Genshaft, S., Kamrava, M., Drakaki, A., Liu, S., Venkat, P., Lee, A., Chang, A.
Published in Journal of thoracic oncology (01.10.2021)
Published in Journal of thoracic oncology (01.10.2021)
Get full text
Journal Article
699P Atezolizumab monotherapy in cisplatin-ineligible patients with previously untreated metastatic urothelial carcinoma: 5-year response and survival analysis from the phase II IMvigor210 study (cohort 1)
Rosenberg, J.E., Galsky, M.D., Balar, A.V., Loriot, Y., Necchi, A., Hoffman-Censits, J., Srinivas, S., Drakaki, A., Javery, A., Nelson, B., Huang, H.X., Shen, X., van der Heijden, M.S.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
663P First-line nivolumab + cabozantinib vs sunitinib in patients (pts) with advanced renal cell carcinoma (aRCC) in subgroups based on prior nephrectomy in the CheckMate 9ER trial
Porta, C.G., Burotto, M., Suarez Rodriguez, C., Bourlon, M.T., Hsieh, J., Shah, A.Y., Hamzaj, A., Bedke, J., Pook, D., Kessler, E.R., Tomita, Y., Drakaki, A., Zhang, J., Simsek, B., Schwab, G., Escudier, B., Motzer, R.J., Choueiri, T.K., Apolo, A.B., Powles, T.B.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
708P PD-L1 as a predictor of survival in patients with metastatic urothelial carcinoma (mUC) from the phase III DANUBE trial of durvalumab (D) or durvalumab plus tremelimumab (D+T) versus standard of care chemotherapy (SoC)
Bellmunt, J., Powles, T.B., van der Heijden, M.S., Galsky, M.D., He, P., Wang, Z., Xiao, F., Jones, F., Scott, M., Walker, J., Angra, N., Gupta, A., Drakaki, A., Kimura, G., Mizokami, A., Wildsmith, S.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
Association of systemic corticosteroids with overall survival in patients receiving cancer immunotherapy for advanced melanoma, non-small cell lung cancer or urothelial cancer in routine clinical practice
Drakaki, A., Luhn, P., Wakelee, H., Dhillon, P.K., Kent, M., Shim, J., Degaonkar, V., Hoang, T., McNally, V., Chui, S.Y., Gutzmer, R.
Published in Annals of oncology (01.12.2019)
Published in Annals of oncology (01.12.2019)
Get full text
Journal Article
Overall responses and survival in RCC on pegilodecakin with anti-PD-1
Naing, A., Infante, J.R., Wong, D.J., Korn, W.M., Aljumaily, R., Papadopoulos, K.P., Autio, K.A., Pant, S., Bauer, T.M., Drakaki, A., Daver, N.G., Hung, A., Verma, R., Ratti, N., McCauley, S., Van Vlasselaer, P., Tannir, M., Oft, M.
Published in European journal of cancer (1990) (01.03.2019)
Published in European journal of cancer (1990) (01.03.2019)
Get full text
Journal Article
Local Failure and Gleason Score 9-10 Disease Independently Predict for Survival Outcomes: A Meta-Analysis of Six Randomized Trials
Kishan, A.U., Chu, F.I., Wang, X., Seiferheld, W., Pugh, S., Collette, L., Sandler, K.A., Sandler, H.M., Bolla, M., Maingon, P., De Reijke, T., Nickols, N., Chang, A.J., Rettig, M., Drakaki, A., Liu, S., Reiter, R.E., Kupelian, P.A., Steinberg, M.L., King, C.R.
Published in International journal of radiation oncology, biology, physics (01.11.2018)
Published in International journal of radiation oncology, biology, physics (01.11.2018)
Get full text
Journal Article
1130OResponses and durability of clinical benefit in renal cell carcinoma treated with pegilodecakin in combination with anti-PD-1 inhibitors
Tannir, N M, Naing, A, Papadopoulos, K P, Wong, D J, Korn, W M, Aljumaily, R, Autio, K A, Pant, S, Bauer, T M, Drakaki, A, Daver, N, Hung, A, Oft, M, Leveque, J
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article